Author

Peter Ang

Observed names: Ang, Peter, P ANG, P Ang, P C S Ang, P. Ang, P.C.S. Ang, Peter C-S. Ang, Peter C.-S. Ang, Peter C.S. Ang, Peter CS Ang, Peter Cher Siang Ang, Peter Cher-Siang Ang, Por Ang

Institution: Mount Elizabeth Novena Hospital

Observed institutions: National Skin Centre, University Malaya Medical Centre, Allama Iqbal Medical College, Singapore General Hospital, Mount Elizabeth Hospital, Jehangir Hospital, Queen Mary Hospital, Gleneagles Hospital, Mount Elizabeth Novena Hospital, National Cancer Center, Rajiv Gandhi Cancer Institute and Research Centre, Dana-Farber Cancer Institute, Instituto Nacional de Enfermedades Neoplásicas, National Cancer Centre Singapore, Ministry of Manpower, University of Hong Kong

ORCID: 0000-0002-0482-3069

Observed ORCID: 0000-0002-0482-3069

OpenAlex ID: A5035622671

Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families

2019 · Xin Yang, Goska Leslie, et al. · Journal of Clinical Oncology · 435

PDF

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer

2008 · Henry L. Gomez, Dinesh C. Doval, et al. · Journal of Clinical Oncology · 338

PDF

Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol®-PM) in patients with solid tumors

2009 · W.T. Lim, E.H. Tan, et al. · Annals of Oncology · 142

Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients

2008 · Suman Lal, Zee Wan Wong, et al. · Cancer Science · 135

PDF

Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer

2003 · Swan Swan Leong, Eng Huat Tan, et al. · Journal of Clinical Oncology · 125

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

2024 · Yen-Shen Lu, Eznal Izwadi Bin Mohd Mahidin, et al. · Journal of Clinical Oncology · 93

Novel SLC22A16 Polymorphisms and Influence on Doxorubicin Pharmacokinetics in Asian Breast Cancer Patients

2007 · Suman Lal, Zee Wan Wong, et al. · Pharmacogenomics · 91

CBR1andCBR3pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients

2008 · Suman Lal, Edwin Sandanaraj, et al. · Cancer Science · 80

Development of a Next-Generation Sequencing Method for BRCA Mutation Screening

2012 · Maurice Chan, Shen Mo Ji, et al. · Journal of Molecular Diagnostics · 77

Characteristics of Hori naevus: a prospective analysis

2005 · H.L. Ee, H.C. Wong, et al. · British Journal of Dermatology · 72

PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients

2008 · Edwin Sandanaraj, Suman Lal, et al. · Clinical Cancer Research · 71

Classical and Amyopathic Dermatomyositis seen at the National Skin Centre of Singapore: A 3-year Retrospective Review of their Clinical Characteristics and Association with Malignancy

2000 · P Ang, MW Sugeng, et al. · Annals of the Academy of Medicine Singapore · 62

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore

2016 · Edward S Y Wong, Sandhya Shekar, et al. · npj Genomic Medicine · 57

PDF

Improving Indel Detection Specificity of the Ion Torrent PGM Benchtop Sequencer

2012 · Zhen Xuan Yeo, Maurice Chan, et al. · PLoS ONE · 55

PDF

Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women

2012 · Wen Yee Chay, Whee Sze Ong, et al. · Breast Cancer Research · 54

PDF

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population

2012 · M. Chan, S. M. Ji, et al. · Breast Cancer Research and Treatment · 53

Breast carcinoma in women 35 years and younger: a pathological study

2006 · Shanika M. Fernandopulle, Peter Cher-Siang Ang, et al. · Pathology · 39

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer

2011 · Nan-Soon Wong, Elaine ZH Seah, et al. · Pharmacogenetics and Genomics · 38

BRCA1andBRCA2Mutations in an Asian Clinic-based Population Detected Using a Comprehensive Strategy

2007 · Peter Ang, Irene H.K. Lim, et al. · Cancer Epidemiology Biomarkers & Prevention · 37

Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients

2016 · Natalia Sutiman, Joanne Siok Liu Lim, et al. · Clinical Pharmacokinetics · 31

Comparison of Completely versus Incompletely Excised Cutaneous Squamous Cell Carcinomas

2004 · P Ang, AWH Tan, et al. · Annals of the Academy of Medicine Singapore · 31

PDF

Evaluation of Nanofluidics Technology for High-Throughput SNP Genotyping in a Clinical Setting

2011 · Maurice Chan, Mei Wen Chan, et al. · Journal of Molecular Diagnostics · 30

PDF

Cutaneous Rosai-Dorfman disease presenting as pustular and acneiform lesions

1999 · P. Ang, S.H. Tan, et al. · Journal of the American Academy of Dermatology · 30

Detection of a novel Alu‐mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing

2006 · KP‐L Yap, P Ang, et al. · Clinical Genetics · 29

Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese

2018 · Claire Hian Tzer Chan, Prabhakaran Munusamy, et al. · Oncotarget · 28

PDF

Works count: 93

Citation count: 2,680

H-index: 26

I10-index: 44